STUDIES OF PLANTS FOR THE TREATMENT OF BRONCHITIS, ASTHMA AND COVID-19: A LITERATURE REVIEW

Authors

DOI:

https://doi.org/10.47820/recima21.v4i2.2697

Keywords:

study aimed to conduct a literature review to verify the use of plant species

Abstract

Objective: the present study aimed to conduct a literature review to verify the use of plant species in the pathology’s asthma, bronchitis, COVID-19 and to identify the compounds responsible for pharmacological action. Methodology: The research was carried out in the databases Medline, Scielo, Web of Science, Lilacs and Scopus, using the keywords through the descriptors DeCS - Descriptors in Health Sciences. Divided into 3 steps; after adopting the inclusion and exclusion criteria, they were selected and read in full by 3 groups separately. The research resulted in 9 plants divided into 7 families and 8 isolated compounds responsible for therapeutic action. It was concluded that after the literary review in the period mentioned, it was possible to observe the therapeutic potential of plants to attenuate the inflammatory response during the exacerbation of asthma symptoms. However, more clinical studies should be conducted to complement the literature on the use of plant species, and more studies with larger samples and longer-term therapies are needed.

Downloads

Download data is not yet available.

Author Biographies

Gabriela Amaral da Cunha Canella

Estudante de medicina Faculdade Evangélica Mackenzie do Paraná.

Isabela Guerra, Faculdade Evangélica Mackenzie do Paraná

Estudante de medicina Faculdade Evangélica Mackenzie do Paraná.

Isadora Dallarmi Miguel, Faculdade Evangélica Mackenzie do Paraná

Estudante de medicina Faculdade Evangélica Mackenzie do Paraná.

Idoniton da Conceição Fernandes, Universidade Federal do Paraná

Mestrando em Ciências Farmacêuticas Universidade Federal do Paraná.

Luciane Dalarmi , Universidade Federal do Paraná

Prof. Dr (a) do Programa de pós-graduação Ciências Farmacêuticas Universidade Federal do Paraná.

Deise Prehs Montrucchio , Universidade Federal do Paraná

Prof. Dr(a) do programa de pós-graduação Ciências Farmacêuticas Universidade Federal do Paraná.

Marilis Dallarmi Miguel , Universidade Federal do Paraná

Prof. Dr(a) do programa de pós-graduação Ciências Farmacêuticas Universidade Federal do Paraná.

Obdulio Gomes Miguel , Universidade Federal do Paraná

Prof. Dr(a) do programa de pós-graduação Ciências Farmacêuticas Universidade Federal do Paraná.

Josiane de Fatima Gaspari Dias, Universidade Federal do Paraná

Prof. Dr(a) do programa de pós-graduação Ciências Farmacêuticas Universidade Federal do Paraná.

References

ARBEX, M.A. et al. A poluição do ar e o sistema respiratório. J. bras. Pneumol. 2012, vol. 38, n. 5, p. 643-655. Disponível em: doi.org/10.1590/S1806- 37132012000500015.

ALBERT, R. H. Diagnosis and treatment of acute bronchitis. American family physician, v. 82, n. 11, p. 1345-1350, 2010.

ALAGU LAKSHMI, S. et al. Ethnomedicines of Indian origin for combating COVID-19 infection by hampering the viral replication: using structure-based drug discovery approach. Journal of Biomolecular Structure and Dynamics, v. 39, n. 13, p. 4594-4609, 2021.

BLEECKER, E. R. et al. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long- acting beta2-agonists (SIROCCO): a randomised, multicentre, placebo- controlled phase 3 trial. Lancet. 2016, vol. 388, n. 10056, p. 2115–2127. doi: 10.1016/S0140-6736(16)31324-1

BRASIL. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Política Nacional de Práticas Integrativas e Complementares no SUS - PNPIC-SUS / Ministério da Saúde, Secretaria de Atenção à Saúde, Departamento de Atenção Básica. - Brasília: Ministério da Saúde, 2006.a

BRASIL. Ministério da Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Departamento de Assistência Farmacêutica. Política nacional de plantas medicinais e fitoterápicos / Ministério da Saúde, Secretaria de Ciência, Tecnologia e Insumos Estratégicos, Departamento de Assistência Farmacêutica. – Brasília: Ministério da Saúde, 2006.b

BUI, T.T et al. Piper nigrum extract ameliorated allergic inflammation through inhibiting Th2/Th17 responses and mast cells activation. Cellular Immunology, v. 322, p. 64-73, 2017.

CARVALHO, E M. et al. Efficacy and safety of cumaru syrup as complementary therapy in mild persistent asthma: a double-blind, randomized, placebo-controlled study. Brazilian Journal of Pharmaceutical Sciences [online]. 2012, v. 48, n. 4. 629-637. Available from: doi.org/10.1590/S1984-82502012000400006

FERREIRA, E. T, et al. A utilização de plantas medicinais e fitoterápicos: uma revisão integrativa sobre a atuação do enfermeiro. Brazilian Journal of Health Review, v. 2, n. 3, p. 1511-1523, 2019.

GUO, Y.R. et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020, v.7, n. 1, p. 11. doi: 10.1186/s40779-020-00240-0. PMID: 32169119; PMCID: PMC7068984.

HWAN-HEE, J. et al. Anti-inflammatory effects of Salvia plebeia R. Br extract in vitro and in ovalbumin-induced mouse model. Biological research, v. 49, p. 1-11, 2016.

IBRAHIM, M. AA et al. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors. Computers in Biology and Medicine, v. 126, p. 104046, 2020.

KANJANASIRIRAT, P. et al. High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents. Scientific reports, v. 10, n. 1, p. 1-12, 2020

LIM, X.Y; TEH, Bee P; TAN, T.Y.C. Medicinal plants in COVID-19: potential and limitations. Frontiers in pharmacology, v. 12, p. 611408, 2021.

LEE, M-Y et al. Anti-asthmatic effects of Angelica dahurica against ovalbumin-induced airway inflammation via upregulation of heme oxygenase-1. Food and Chemical Toxicology, v. 49, n. 4, p. 829-837, 2011.

MACKENZIE, J.S.; SMITH, D.W. COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don't. Microbiol Aust. 2020, MA20013. doi: 10.1071/MA20013. Epub ahead of print. PMID: 32226946; PMCID: PMC7086482.

MAYOCLINIC. Bronchitis. April 11, 2017. Disponível em: https://www.mayoclinic.org/diseases-conditions/bronchitis/symptoms-causes/syc-20355566. Acesso em 16 dez. de 2022.

MEGA, T. P. et al. Use of medicinal herbs by patients with severe asthma managed at a Referral Center. Brazilian Journal of Pharmaceutical Sciences, v. 47, p. 643-649, 2011

MEIRELES, T. Nosso país está em 1º lugar no ranking mundial de diversidade. Publicado em 12 janeiro 2021. Disponível em: https://www.wwf.org.br/?77530/Conheca-um-animal-de-cada-bioma-brasileiro. Acesso em 10 de outubro de 2022.

MERAD, M.; MARTIN J.C. Pathological inflammation in patients with COVID- 19: a key role for monocytes and macrophages. Nat Rev. Immunol. 2020, v. 20, n.6, p. 355-362. doi: 10.1038/s41577-020-0331-4.

MOURA, J.A.R et al. Tratamento profilático da asma. Jornal de Pediatria. 2002, vol 78, n. 2, p 141-150. doi.org/10.1590/S0021-75572002000800005.

MOURÃO, P. S. Et al. Medicinal plants used in the treatment of chronic respiratory diseases: From 2010 to 2020. Research, Society and Development, [S. l.], v. 10, n. 8, p. e29710817179, 2021. DOI: 10.33448/rsd-v10i8.17179.

OMS.Organização Mundial da Saúde. tualizações contínuas sobre a doença coronavírus (COVID- 19). Eventos conforme acontecem. 2021.Disponível em: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events- as-they-happen (acessado em julho de 2021)

SBPT. Sociedade Brasileira de Pneumologia e Tisiologia. Disponível em: https://sbpt.org.br/portal/espaco-saude-respiratoria-asma/. Acesso em 16 de dez 2022.

SÁ- FILHO, G. F. de et al. Medicinal plants used in the Brazilian caatinga and the therapeutic potential of secondary metabolites: a review. Research, Society and Development, [S. l.], v. 10, n. 13, p. e140101321096, 2021. DOI: 10.33448/rsd-v10i13.21096.

SHREE, P. et al. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants–Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi)–a molecular docking study. Journal of Biomolecular Structure and Dynamics, v. 40, n. 1, p. 190-203, 2022.

YANG, S, et al. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition. Journal of ethnopharmacology, v. 200, p. 147-155, 2017.

WAN, L. et al. Preventive and therapeutic effects of thymol in a lipopolysaccharide-induced acute lung injury mice model. Inflammation, v. 41, n. 1, p. 183-192, 2018.

Downloads

Published

08/02/2023

How to Cite

Amaral da Cunha Canella, G. ., Guerra, I., Dallarmi Miguel, I. ., da Conceição Fernandes, I., Dalarmi , L. ., Prehs Montrucchio , D. ., … Gaspari Dias, J. de F. (2023). STUDIES OF PLANTS FOR THE TREATMENT OF BRONCHITIS, ASTHMA AND COVID-19: A LITERATURE REVIEW. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218, 4(2), e422697. https://doi.org/10.47820/recima21.v4i2.2697

Issue

Vol. 4 No. 2 (2023): EDITORIAL - CLICK HERE TO ACCESS THE ARTICLES

Section

ARTIGOS

Categories

License

Copyright (c) 2023 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores  e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.